Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Aroa Biosurgery Ltd ( (AU:ARX) ) is now available.
Aroa Biosurgery Ltd has announced its upcoming Annual General Meeting (AGM) scheduled for August 20, 2025, which will be conducted as a hybrid meeting allowing both physical and online attendance. The meeting will cover several key items including the board chair’s and CEO’s addresses, consideration of financial results, and resolutions on director re-election, auditor’s remuneration, and the issuance of equity securities under the Aroa Omnibus Incentive Plan. This AGM is significant for stakeholders as it includes important resolutions that could impact the company’s governance and financial strategies.
The most recent analyst rating on (AU:ARX) stock is a Buy with a A$0.93 price target. To see the full list of analyst forecasts on Aroa Biosurgery Ltd stock, see the AU:ARX Stock Forecast page.
More about Aroa Biosurgery Ltd
Aroa Biosurgery Ltd operates in the medical technology industry, focusing on the development and commercialization of regenerative tissue products. The company is known for its innovative solutions in wound care and soft tissue repair, catering to a global market with a strong emphasis on improving patient outcomes.
Average Trading Volume: 224,910
Technical Sentiment Signal: Buy
Current Market Cap: A$220.8M
Find detailed analytics on ARX stock on TipRanks’ Stock Analysis page.